Epigenetic factors in atherosclerosis: DNA methylation, folic acid metabolism, and intestinal microbiota
Many clients note changing eating habits: wanting lighter food, less sweets, less "eating from boredom." Average weight loss 5-8% of initial weight in first 3 months
Dermal fillers like Juvderm can help add volume to the cheeks and lips which can help with patients who notice a hollowed-out appearance
Lobeglitazone, a PPAR/ agonist licensed in Korea for treatment of T2DM, has recently been studied in a pilot trial recruiting diabetic NASH patients diagnosed by CAP values on Fibroscan
Its important to check how well the treatment is working during this time
My hope is that this narrative shifts as we begin to learn more about GLP-1s, proper dosing, and the additional benefits outside of weight loss